Introduction
Inflammation plays a vital role in accentuating the formation of atherosclerotic plaque, and thus the measurement of inflammatory markers provide a method of assessing cardiovascular risk. Among the inflammatory markers, of late C-Reactive protein, is considered as inflammatory markers for coronary artery disease.CRP is an acute phase protein produced by liver, in response to any inflammation. It is used as a marker for low grade systemic inflammation. Conditions like Smoking, Blood Pressure and elevated cholesterol levels can also elicit inflammatory reactions that are detectable with C-reactive protein. However, CRP lack the sensitivity when inflammation are within normal range. More recently high sensitive CRP (hs-CRP) is used to detect the low level inflammation when it is within the normal range 1 . This lack of sensitivity and specificity with measuring CRP, resulted in the estimation of CRP using laser nephelometry , which can detect the low level inflammation, even when it is within normal range.
Atherosclerosis in coronary arteries is not only due to lipid deposits, but, also due to systemic inflammation, both playing a major role in atherothrombotic inception and progression 2 . Few studies have demonstrated that the possible association between CRP levels and coronary artery disease 3 . Thakur et al., estimated the levels of hs-CRP in coronary artery disease and found that there is a significant increase in hs-CRP levels in coronary artery disease 4 .In another study, Wolfgang et al., used hs-CRP to estimate the association of inflammation with the first incidence of coronary artery disease and concluded that hs-CRP is a sensitive systemic inflammatory marker for predicting the risk of CAD and also suggested that low grade inflammation is involved in the pathogenesis of atherosclerosis 5 . However, there are no studies that could emphasis on the cut-off value of hs-CRP in estimating the risks in coronary artery disease patients in south Indian population. This study was designed to estimate the hs-CRP levels in recently diagnosed coronary artery disease (CAD) and to see whether it can be used as a risk marker for CAD in South India urban population (Chennai).
II.

Aim Of The Study
To measure hs-CRP value in patients with coronary artery disease and to compare it with controls.
III.
Materials And Methods
Study population -45 patients, who were recently diagnosed with coronary artery disease, were recruited for the study . They were selected after a questionnaire analysis. The diagnosis for cad was confirmed by clinical presentation and with any two positive investigations like ECG, Echocardiogram, Cardiac Enzymes & Angiogram. 45 age and sex matched controls were selected. The study was approved by the institutional ethical committee. A well informed written consent was obtained from both the cases and controls after briefing them about the study. Inclusion criteria: Age ranging between 35 to 80 years. Both the sex were included in this study. Exclusion criteria: Recent infection, Inflammatory disease eg., arthiritis., who were under NSAIDS The study was done in Sree Balaji Medical College & Hospital (SBMC&H). 3ml of venous blood was collected from all the cases and control to assess the hs-CRP value. hs-CRP value is measured by using immunoturbidimetric test in the central laboratory in SBMCH. Lipid profile reports were collected from the patient's record.
Statistical Analysis: Results were tabulated and the values were expressed in Mean ± Standard Deviation. Significance was assessed by using Unpaired Student t-test. Pearson correlation analysis was also done. We can observe significance only in the BMI between cases and controls. V.
IV.
Results
Discussion
hs-CRP is divided into three risk groups according to the American Heart Association.
In our study, out of 45 cases 43 have hs-CRP values more than 3 mg/l, this clearly proves that our patients belong to high risk category in consistent with previous studies 6 . Out of 45 controls, 34 are in moderate risk group and 11 are in low risk group (table 3 and figure 4 ). More number of subjects falling under the moderate risk group might be either due to underlying systemic illness like Diabetes Mellitus and Hypertension or these controls might have impending thrombogenesis which is reflected in there hs-CRP values.
In our study we observed there is an increased concentration of total cholesterol and low density lipoprotein but decrease in high density lipoprotein in cases when compared to controls (table 2) The cause of elevated levels of hs-CRP seems to be due to persistent inflammation in CAD. hs-CRP enhances atherosclerosis by activating complement pathway and induces adhesion molecule expression by human endothelial cells, monocyte recruitment into the arterial wall. It enhances the entry of LDL particles into macrophages. It induce the plasminogen activator inhibitor-1 expression and it also cause endothelial dysfunction. Recent studies states that hs-CRP can be produced within the vascular smooth muscle of diseased coronary arteries and this may directly lead to expression of several mediators of atherothrombotic process 7 .
VI.
Conclusion
With this study we conclude that hs-CRP can be used as a risk-marker for coronary artery disease. In clinical scenario, hs-CRP estimation can be employed as a screening tool in the prediction of future coronary artery events. hs-CRP can also be used for primary prevention of CAD.
